Detalhe da pesquisa
1.
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.
Nat Commun
; 15(1): 1312, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346978
2.
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer.
Cancer Res
; 82(18): 3291-3306, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862581
3.
CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer.
Cancers (Basel)
; 13(23)2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884993
4.
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.
Nat Commun
; 11(1): 404, 2020 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31964880
5.
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells.
Life Sci Alliance
; 2(1)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760554
6.
miR200-regulated CXCL12ß promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.
Nat Commun
; 9(1): 1056, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535360
7.
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Cancer Cell
; 33(3): 463-479.e10, 2018 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29455927